Hermes Biosciences

High-Yield exosome isolation

Hermes Biosciences lists 1–10 employees and has $6.0M in recorded funding across 1 round.

Employees
1–10
Business Model
B2B
Total Funding
$6.0M
Last Round
$6.0M SeedNov 2025
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.

About

The Hermes Biosciences team brings decades of experience building and scaling innovative biotech tools, with a strong track record of launching impactful life sciences and diagnostics products. By combining deep molecular biology insight with engineering innovation, the team is developing a next-generation extracellular vesicle isolation solution to accelerate discovery for researchers. The technology captures the biological units of communication between cells at higher yield and quality, increasing their value in understanding, diagnosing, and treating cancer, degenerative diseases, and conditions in regenerative medicine.

Summary

Hermes Biosciences is a Biotech company. It lists 1–10 employees. It has raised $6.0M in total across 1 round, most recently a $6.0M Seed round in Nov 2025. Investors include Genoa Ventures, Paladin Capital Group and Vertical Venture Partners.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedNov 2025
$6.0M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Hermes Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/hermes-biosciences"><img src="https://indexed.vc/api/badge/company/hermes-biosciences" alt="Hermes Biosciences on Indexed.vc" width="260" height="76" /></a>